{
  "ticker": "ABBV",
  "year": 2024,
  "quarter": 1,
  "last_updated": "2025-04-19T08:01:13.559986",
  "count": 157,
  "transactions": [
    {
      "id": 14329,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Donoghoe Nicholas",
      "reporting_owner_cik": "0001762951",
      "reporting_owner_position": "EVP, CHIEF BUS/STRAT OFFICER",
      "transaction_date": "2024-03-20",
      "transaction_shares": "21082",
      "transaction_price": "176.30",
      "transaction_type": "S",
      "shares_after_transaction": "55903"
    },
    {
      "id": 27190,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Donoghoe Nicholas",
      "reporting_owner_cik": "0001762951",
      "reporting_owner_position": "EVP, CHIEF BUS/STRAT OFFICER",
      "transaction_date": "2024-03-20",
      "transaction_shares": "21082",
      "transaction_price": "176.30",
      "transaction_type": "S",
      "shares_after_transaction": "55903"
    },
    {
      "id": 44022,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Donoghoe Nicholas",
      "reporting_owner_cik": "0001762951",
      "reporting_owner_position": "EVP, CHIEF BUS/STRAT OFFICER",
      "transaction_date": "2024-03-20",
      "transaction_shares": "21082",
      "transaction_price": "176.30",
      "transaction_type": "S",
      "shares_after_transaction": "55903"
    },
    {
      "id": 63637,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Donoghoe Nicholas",
      "reporting_owner_cik": "0001762951",
      "reporting_owner_position": "EVP, CHIEF BUS/STRAT OFFICER",
      "transaction_date": "2024-03-20",
      "transaction_shares": "21082",
      "transaction_price": "176.30",
      "transaction_type": "S",
      "shares_after_transaction": "55903"
    },
    {
      "id": 85545,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Donoghoe Nicholas",
      "reporting_owner_cik": "0001762951",
      "reporting_owner_position": "EVP, CHIEF BUS/STRAT OFFICER",
      "transaction_date": "2024-03-20",
      "transaction_shares": "21082",
      "transaction_price": "176.30",
      "transaction_type": "S",
      "shares_after_transaction": "55903"
    },
    {
      "id": 14326,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Stewart Jeffrey Ryan",
      "reporting_owner_cik": "0001761675",
      "reporting_owner_position": "EVP, CHIEF COMMERCIAL OFFICER",
      "transaction_date": "2024-03-18",
      "transaction_shares": "26110",
      "transaction_price": "61.36",
      "transaction_type": "M",
      "shares_after_transaction": "119890"
    },
    {
      "id": 27184,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Stewart Jeffrey Ryan",
      "reporting_owner_cik": "0001761675",
      "reporting_owner_position": "EVP, CHIEF COMMERCIAL OFFICER",
      "transaction_date": "2024-03-18",
      "transaction_shares": "26110",
      "transaction_price": "61.36",
      "transaction_type": "M",
      "shares_after_transaction": "119890"
    },
    {
      "id": 44013,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Stewart Jeffrey Ryan",
      "reporting_owner_cik": "0001761675",
      "reporting_owner_position": "EVP, CHIEF COMMERCIAL OFFICER",
      "transaction_date": "2024-03-18",
      "transaction_shares": "26110",
      "transaction_price": "61.36",
      "transaction_type": "M",
      "shares_after_transaction": "119890"
    },
    {
      "id": 63628,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Stewart Jeffrey Ryan",
      "reporting_owner_cik": "0001761675",
      "reporting_owner_position": "EVP, CHIEF COMMERCIAL OFFICER",
      "transaction_date": "2024-03-18",
      "transaction_shares": "26110",
      "transaction_price": "61.36",
      "transaction_type": "M",
      "shares_after_transaction": "119890"
    },
    {
      "id": 85536,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Stewart Jeffrey Ryan",
      "reporting_owner_cik": "0001761675",
      "reporting_owner_position": "EVP, CHIEF COMMERCIAL OFFICER",
      "transaction_date": "2024-03-18",
      "transaction_shares": "26110",
      "transaction_price": "61.36",
      "transaction_type": "M",
      "shares_after_transaction": "119890"
    },
    {
      "id": 14339,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "RICHMOND TIMOTHY J.",
      "reporting_owner_cik": "0001563523",
      "reporting_owner_position": "EVP, CHIEF HR OFFICER",
      "transaction_date": "2024-03-01",
      "transaction_shares": "45700",
      "transaction_price": "61.36",
      "transaction_type": "M",
      "shares_after_transaction": "89517"
    },
    {
      "id": 27200,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "RICHMOND TIMOTHY J.",
      "reporting_owner_cik": "0001563523",
      "reporting_owner_position": "EVP, CHIEF HR OFFICER",
      "transaction_date": "2024-03-01",
      "transaction_shares": "45700",
      "transaction_price": "61.36",
      "transaction_type": "M",
      "shares_after_transaction": "89517"
    },
    {
      "id": 44035,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "RICHMOND TIMOTHY J.",
      "reporting_owner_cik": "0001563523",
      "reporting_owner_position": "EVP, CHIEF HR OFFICER",
      "transaction_date": "2024-03-01",
      "transaction_shares": "45700",
      "transaction_price": "61.36",
      "transaction_type": "M",
      "shares_after_transaction": "89517"
    },
    {
      "id": 63650,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "RICHMOND TIMOTHY J.",
      "reporting_owner_cik": "0001563523",
      "reporting_owner_position": "EVP, CHIEF HR OFFICER",
      "transaction_date": "2024-03-01",
      "transaction_shares": "45700",
      "transaction_price": "61.36",
      "transaction_type": "M",
      "shares_after_transaction": "89517"
    },
    {
      "id": 85559,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "RICHMOND TIMOTHY J.",
      "reporting_owner_cik": "0001563523",
      "reporting_owner_position": "EVP, CHIEF HR OFFICER",
      "transaction_date": "2024-03-01",
      "transaction_shares": "45700",
      "transaction_price": "61.36",
      "transaction_type": "M",
      "shares_after_transaction": "89517"
    },
    {
      "id": 14324,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Hudson Thomas J",
      "reporting_owner_cik": "0001781947",
      "reporting_owner_position": "SVP, CSO, GLOBAL RESEARCH",
      "transaction_date": "2024-02-28",
      "transaction_shares": "20634",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "107267"
    },
    {
      "id": 14328,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Thakkar Roopal",
      "reporting_owner_cik": "0002004979",
      "reporting_owner_position": "SVP, CMO, GLOBAL THERAPEUTICS",
      "transaction_date": "2024-02-28",
      "transaction_shares": "4914",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "23259"
    },
    {
      "id": 14331,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Buckbee Kevin K",
      "reporting_owner_cik": "0001968528",
      "reporting_owner_position": "SVP, CONTROLLER",
      "transaction_date": "2024-02-28",
      "transaction_shares": "5339",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "13872"
    },
    {
      "id": 14333,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Donoghoe Nicholas",
      "reporting_owner_cik": "0001762951",
      "reporting_owner_position": "EVP, CHIEF BUS/STRAT OFFICER",
      "transaction_date": "2024-02-28",
      "transaction_shares": "16771",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "76985"
    },
    {
      "id": 14337,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Michael Robert A.",
      "reporting_owner_cik": "0001699914",
      "reporting_owner_position": "PRES & CHIEF OPERATING OFFICER",
      "transaction_date": "2024-02-28",
      "transaction_shares": "37638",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "145964"
    },
    {
      "id": 14345,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Siatis Perry C",
      "reporting_owner_cik": "0001951400",
      "reporting_owner_position": "EVP, GC AND SECRETARY",
      "transaction_date": "2024-02-28",
      "transaction_shares": "7885",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "20288"
    },
    {
      "id": 14347,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "RICHMOND TIMOTHY J.",
      "reporting_owner_cik": "0001563523",
      "reporting_owner_position": "EVP, CHIEF HR OFFICER",
      "transaction_date": "2024-02-28",
      "transaction_shares": "23847",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "43817"
    },
    {
      "id": 14348,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Stewart Jeffrey Ryan",
      "reporting_owner_cik": "0001761675",
      "reporting_owner_position": "EVP, CHIEF COMMERCIAL OFFICER",
      "transaction_date": "2024-02-28",
      "transaction_shares": "26121",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "93780"
    },
    {
      "id": 14349,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "GONZALEZ RICHARD A",
      "reporting_owner_cik": "0001239127",
      "reporting_owner_position": "CHAIRMAN OF THE BOARD AND CEO",
      "transaction_date": "2024-02-28",
      "transaction_shares": "110249",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "657715"
    },
    {
      "id": 14351,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "SALEKI-GERHARDT AZITA",
      "reporting_owner_cik": "0001563545",
      "reporting_owner_position": "EVP, CHIEF OPERATIONS OFFICER",
      "transaction_date": "2024-02-28",
      "transaction_shares": "23966",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "219978"
    },
    {
      "id": 27182,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Hudson Thomas J",
      "reporting_owner_cik": "0001781947",
      "reporting_owner_position": "SVP, CSO, GLOBAL RESEARCH",
      "transaction_date": "2024-02-28",
      "transaction_shares": "20634",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "107267"
    },
    {
      "id": 27188,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Thakkar Roopal",
      "reporting_owner_cik": "0002004979",
      "reporting_owner_position": "SVP, CMO, GLOBAL THERAPEUTICS",
      "transaction_date": "2024-02-28",
      "transaction_shares": "4914",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "23259"
    },
    {
      "id": 27192,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Buckbee Kevin K",
      "reporting_owner_cik": "0001968528",
      "reporting_owner_position": "SVP, CONTROLLER",
      "transaction_date": "2024-02-28",
      "transaction_shares": "5339",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "13872"
    },
    {
      "id": 27194,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Donoghoe Nicholas",
      "reporting_owner_cik": "0001762951",
      "reporting_owner_position": "EVP, CHIEF BUS/STRAT OFFICER",
      "transaction_date": "2024-02-28",
      "transaction_shares": "16771",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "76985"
    },
    {
      "id": 27198,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Michael Robert A.",
      "reporting_owner_cik": "0001699914",
      "reporting_owner_position": "PRES & CHIEF OPERATING OFFICER",
      "transaction_date": "2024-02-28",
      "transaction_shares": "37638",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "145964"
    },
    {
      "id": 27206,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Siatis Perry C",
      "reporting_owner_cik": "0001951400",
      "reporting_owner_position": "EVP, GC AND SECRETARY",
      "transaction_date": "2024-02-28",
      "transaction_shares": "7885",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "20288"
    },
    {
      "id": 27208,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "RICHMOND TIMOTHY J.",
      "reporting_owner_cik": "0001563523",
      "reporting_owner_position": "EVP, CHIEF HR OFFICER",
      "transaction_date": "2024-02-28",
      "transaction_shares": "23847",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "43817"
    },
    {
      "id": 27209,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Stewart Jeffrey Ryan",
      "reporting_owner_cik": "0001761675",
      "reporting_owner_position": "EVP, CHIEF COMMERCIAL OFFICER",
      "transaction_date": "2024-02-28",
      "transaction_shares": "26121",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "93780"
    },
    {
      "id": 27210,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "GONZALEZ RICHARD A",
      "reporting_owner_cik": "0001239127",
      "reporting_owner_position": "CHAIRMAN OF THE BOARD AND CEO",
      "transaction_date": "2024-02-28",
      "transaction_shares": "110249",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "657715"
    },
    {
      "id": 27212,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "SALEKI-GERHARDT AZITA",
      "reporting_owner_cik": "0001563545",
      "reporting_owner_position": "EVP, CHIEF OPERATIONS OFFICER",
      "transaction_date": "2024-02-28",
      "transaction_shares": "23966",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "219978"
    },
    {
      "id": 44010,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Hudson Thomas J",
      "reporting_owner_cik": "0001781947",
      "reporting_owner_position": "SVP, CSO, GLOBAL RESEARCH",
      "transaction_date": "2024-02-28",
      "transaction_shares": "20634",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "107267"
    },
    {
      "id": 44017,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Thakkar Roopal",
      "reporting_owner_cik": "0002004979",
      "reporting_owner_position": "SVP, CMO, GLOBAL THERAPEUTICS",
      "transaction_date": "2024-02-28",
      "transaction_shares": "4914",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "23259"
    },
    {
      "id": 44025,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Buckbee Kevin K",
      "reporting_owner_cik": "0001968528",
      "reporting_owner_position": "SVP, CONTROLLER",
      "transaction_date": "2024-02-28",
      "transaction_shares": "5339",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "13872"
    },
    {
      "id": 44027,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Donoghoe Nicholas",
      "reporting_owner_cik": "0001762951",
      "reporting_owner_position": "EVP, CHIEF BUS/STRAT OFFICER",
      "transaction_date": "2024-02-28",
      "transaction_shares": "16771",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "76985"
    },
    {
      "id": 44032,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Michael Robert A.",
      "reporting_owner_cik": "0001699914",
      "reporting_owner_position": "PRES & CHIEF OPERATING OFFICER",
      "transaction_date": "2024-02-28",
      "transaction_shares": "37638",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "145964"
    },
    {
      "id": 44041,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Siatis Perry C",
      "reporting_owner_cik": "0001951400",
      "reporting_owner_position": "EVP, GC AND SECRETARY",
      "transaction_date": "2024-02-28",
      "transaction_shares": "7885",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "20288"
    },
    {
      "id": 44046,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "RICHMOND TIMOTHY J.",
      "reporting_owner_cik": "0001563523",
      "reporting_owner_position": "EVP, CHIEF HR OFFICER",
      "transaction_date": "2024-02-28",
      "transaction_shares": "23847",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "43817"
    },
    {
      "id": 44047,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Stewart Jeffrey Ryan",
      "reporting_owner_cik": "0001761675",
      "reporting_owner_position": "EVP, CHIEF COMMERCIAL OFFICER",
      "transaction_date": "2024-02-28",
      "transaction_shares": "26121",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "93780"
    },
    {
      "id": 44048,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "GONZALEZ RICHARD A",
      "reporting_owner_cik": "0001239127",
      "reporting_owner_position": "CHAIRMAN OF THE BOARD AND CEO",
      "transaction_date": "2024-02-28",
      "transaction_shares": "110249",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "657715"
    },
    {
      "id": 44051,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "SALEKI-GERHARDT AZITA",
      "reporting_owner_cik": "0001563545",
      "reporting_owner_position": "EVP, CHIEF OPERATIONS OFFICER",
      "transaction_date": "2024-02-28",
      "transaction_shares": "23966",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "219978"
    },
    {
      "id": 63625,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Hudson Thomas J",
      "reporting_owner_cik": "0001781947",
      "reporting_owner_position": "SVP, CSO, GLOBAL RESEARCH",
      "transaction_date": "2024-02-28",
      "transaction_shares": "20634",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "107267"
    },
    {
      "id": 63632,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Thakkar Roopal",
      "reporting_owner_cik": "0002004979",
      "reporting_owner_position": "SVP, CMO, GLOBAL THERAPEUTICS",
      "transaction_date": "2024-02-28",
      "transaction_shares": "4914",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "23259"
    },
    {
      "id": 63640,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Buckbee Kevin K",
      "reporting_owner_cik": "0001968528",
      "reporting_owner_position": "SVP, CONTROLLER",
      "transaction_date": "2024-02-28",
      "transaction_shares": "5339",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "13872"
    },
    {
      "id": 63642,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Donoghoe Nicholas",
      "reporting_owner_cik": "0001762951",
      "reporting_owner_position": "EVP, CHIEF BUS/STRAT OFFICER",
      "transaction_date": "2024-02-28",
      "transaction_shares": "16771",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "76985"
    },
    {
      "id": 63647,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Michael Robert A.",
      "reporting_owner_cik": "0001699914",
      "reporting_owner_position": "PRES & CHIEF OPERATING OFFICER",
      "transaction_date": "2024-02-28",
      "transaction_shares": "37638",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "145964"
    },
    {
      "id": 63656,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Siatis Perry C",
      "reporting_owner_cik": "0001951400",
      "reporting_owner_position": "EVP, GC AND SECRETARY",
      "transaction_date": "2024-02-28",
      "transaction_shares": "7885",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "20288"
    },
    {
      "id": 63661,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "RICHMOND TIMOTHY J.",
      "reporting_owner_cik": "0001563523",
      "reporting_owner_position": "EVP, CHIEF HR OFFICER",
      "transaction_date": "2024-02-28",
      "transaction_shares": "23847",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "43817"
    },
    {
      "id": 63662,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Stewart Jeffrey Ryan",
      "reporting_owner_cik": "0001761675",
      "reporting_owner_position": "EVP, CHIEF COMMERCIAL OFFICER",
      "transaction_date": "2024-02-28",
      "transaction_shares": "26121",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "93780"
    },
    {
      "id": 63663,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "GONZALEZ RICHARD A",
      "reporting_owner_cik": "0001239127",
      "reporting_owner_position": "CHAIRMAN OF THE BOARD AND CEO",
      "transaction_date": "2024-02-28",
      "transaction_shares": "110249",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "657715"
    },
    {
      "id": 63666,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "SALEKI-GERHARDT AZITA",
      "reporting_owner_cik": "0001563545",
      "reporting_owner_position": "EVP, CHIEF OPERATIONS OFFICER",
      "transaction_date": "2024-02-28",
      "transaction_shares": "23966",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "219978"
    },
    {
      "id": 85533,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Hudson Thomas J",
      "reporting_owner_cik": "0001781947",
      "reporting_owner_position": "SVP, CSO, GLOBAL RESEARCH",
      "transaction_date": "2024-02-28",
      "transaction_shares": "20634",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "107267"
    },
    {
      "id": 85540,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Thakkar Roopal",
      "reporting_owner_cik": "0002004979",
      "reporting_owner_position": "SVP, CMO, GLOBAL THERAPEUTICS",
      "transaction_date": "2024-02-28",
      "transaction_shares": "4914",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "23259"
    },
    {
      "id": 85548,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Buckbee Kevin K",
      "reporting_owner_cik": "0001968528",
      "reporting_owner_position": "SVP, CONTROLLER",
      "transaction_date": "2024-02-28",
      "transaction_shares": "5339",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "13872"
    },
    {
      "id": 85550,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Donoghoe Nicholas",
      "reporting_owner_cik": "0001762951",
      "reporting_owner_position": "EVP, CHIEF BUS/STRAT OFFICER",
      "transaction_date": "2024-02-28",
      "transaction_shares": "16771",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "76985"
    },
    {
      "id": 85556,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Michael Robert A.",
      "reporting_owner_cik": "0001699914",
      "reporting_owner_position": "PRES & CHIEF OPERATING OFFICER",
      "transaction_date": "2024-02-28",
      "transaction_shares": "37638",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "145964"
    },
    {
      "id": 85565,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Siatis Perry C",
      "reporting_owner_cik": "0001951400",
      "reporting_owner_position": "EVP, GC AND SECRETARY",
      "transaction_date": "2024-02-28",
      "transaction_shares": "7885",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "20288"
    },
    {
      "id": 85571,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "RICHMOND TIMOTHY J.",
      "reporting_owner_cik": "0001563523",
      "reporting_owner_position": "EVP, CHIEF HR OFFICER",
      "transaction_date": "2024-02-28",
      "transaction_shares": "23847",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "43817"
    },
    {
      "id": 85572,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Stewart Jeffrey Ryan",
      "reporting_owner_cik": "0001761675",
      "reporting_owner_position": "EVP, CHIEF COMMERCIAL OFFICER",
      "transaction_date": "2024-02-28",
      "transaction_shares": "26121",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "93780"
    },
    {
      "id": 85573,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "GONZALEZ RICHARD A",
      "reporting_owner_cik": "0001239127",
      "reporting_owner_position": "CHAIRMAN OF THE BOARD AND CEO",
      "transaction_date": "2024-02-28",
      "transaction_shares": "110249",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "657715"
    },
    {
      "id": 85576,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "SALEKI-GERHARDT AZITA",
      "reporting_owner_cik": "0001563545",
      "reporting_owner_position": "EVP, CHIEF OPERATIONS OFFICER",
      "transaction_date": "2024-02-28",
      "transaction_shares": "23966",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "219978"
    },
    {
      "id": 14342,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "GONZALEZ RICHARD A",
      "reporting_owner_cik": "0001239127",
      "reporting_owner_position": "CHAIRMAN OF THE BOARD AND CEO",
      "transaction_date": "2024-02-27",
      "transaction_shares": "1670",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "770489"
    },
    {
      "id": 27203,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "GONZALEZ RICHARD A",
      "reporting_owner_cik": "0001239127",
      "reporting_owner_position": "CHAIRMAN OF THE BOARD AND CEO",
      "transaction_date": "2024-02-27",
      "transaction_shares": "1670",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "770489"
    },
    {
      "id": 44038,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "GONZALEZ RICHARD A",
      "reporting_owner_cik": "0001239127",
      "reporting_owner_position": "CHAIRMAN OF THE BOARD AND CEO",
      "transaction_date": "2024-02-27",
      "transaction_shares": "1670",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "770489"
    },
    {
      "id": 63653,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "GONZALEZ RICHARD A",
      "reporting_owner_cik": "0001239127",
      "reporting_owner_position": "CHAIRMAN OF THE BOARD AND CEO",
      "transaction_date": "2024-02-27",
      "transaction_shares": "1670",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "770489"
    },
    {
      "id": 85562,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "GONZALEZ RICHARD A",
      "reporting_owner_cik": "0001239127",
      "reporting_owner_position": "CHAIRMAN OF THE BOARD AND CEO",
      "transaction_date": "2024-02-27",
      "transaction_shares": "1670",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "770489"
    },
    {
      "id": 14330,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Reents Scott T",
      "reporting_owner_cik": "0001937048",
      "reporting_owner_position": "EVP, CHIEF FINANCIAL OFFICER",
      "transaction_date": "2024-02-23",
      "transaction_shares": "14140",
      "transaction_price": "61.36",
      "transaction_type": "M",
      "shares_after_transaction": "41205"
    },
    {
      "id": 14346,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Siatis Perry C",
      "reporting_owner_cik": "0001951400",
      "reporting_owner_position": "EVP, GC AND SECRETARY",
      "transaction_date": "2024-02-23",
      "transaction_shares": "2919",
      "transaction_price": "144.54",
      "transaction_type": "M",
      "shares_after_transaction": "31092"
    },
    {
      "id": 27191,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Reents Scott T",
      "reporting_owner_cik": "0001937048",
      "reporting_owner_position": "EVP, CHIEF FINANCIAL OFFICER",
      "transaction_date": "2024-02-23",
      "transaction_shares": "14140",
      "transaction_price": "61.36",
      "transaction_type": "M",
      "shares_after_transaction": "41205"
    },
    {
      "id": 27207,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Siatis Perry C",
      "reporting_owner_cik": "0001951400",
      "reporting_owner_position": "EVP, GC AND SECRETARY",
      "transaction_date": "2024-02-23",
      "transaction_shares": "2919",
      "transaction_price": "144.54",
      "transaction_type": "M",
      "shares_after_transaction": "31092"
    },
    {
      "id": 44024,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Reents Scott T",
      "reporting_owner_cik": "0001937048",
      "reporting_owner_position": "EVP, CHIEF FINANCIAL OFFICER",
      "transaction_date": "2024-02-23",
      "transaction_shares": "14140",
      "transaction_price": "61.36",
      "transaction_type": "M",
      "shares_after_transaction": "41205"
    },
    {
      "id": 44042,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Siatis Perry C",
      "reporting_owner_cik": "0001951400",
      "reporting_owner_position": "EVP, GC AND SECRETARY",
      "transaction_date": "2024-02-23",
      "transaction_shares": "2919",
      "transaction_price": "144.54",
      "transaction_type": "M",
      "shares_after_transaction": "31092"
    },
    {
      "id": 63639,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Reents Scott T",
      "reporting_owner_cik": "0001937048",
      "reporting_owner_position": "EVP, CHIEF FINANCIAL OFFICER",
      "transaction_date": "2024-02-23",
      "transaction_shares": "14140",
      "transaction_price": "61.36",
      "transaction_type": "M",
      "shares_after_transaction": "41205"
    },
    {
      "id": 63657,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Siatis Perry C",
      "reporting_owner_cik": "0001951400",
      "reporting_owner_position": "EVP, GC AND SECRETARY",
      "transaction_date": "2024-02-23",
      "transaction_shares": "2919",
      "transaction_price": "144.54",
      "transaction_type": "M",
      "shares_after_transaction": "31092"
    },
    {
      "id": 85547,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Reents Scott T",
      "reporting_owner_cik": "0001937048",
      "reporting_owner_position": "EVP, CHIEF FINANCIAL OFFICER",
      "transaction_date": "2024-02-23",
      "transaction_shares": "14140",
      "transaction_price": "61.36",
      "transaction_type": "M",
      "shares_after_transaction": "41205"
    },
    {
      "id": 85566,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Siatis Perry C",
      "reporting_owner_cik": "0001951400",
      "reporting_owner_position": "EVP, GC AND SECRETARY",
      "transaction_date": "2024-02-23",
      "transaction_shares": "2919",
      "transaction_price": "144.54",
      "transaction_type": "M",
      "shares_after_transaction": "31092"
    },
    {
      "id": 14327,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "SALEKI-GERHARDT AZITA",
      "reporting_owner_cik": "0001563545",
      "reporting_owner_position": "EVP, CHIEF OPERATIONS OFFICER",
      "transaction_date": "2024-02-21",
      "transaction_shares": "52870",
      "transaction_price": "58.88",
      "transaction_type": "M",
      "shares_after_transaction": "296814"
    },
    {
      "id": 27185,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "SALEKI-GERHARDT AZITA",
      "reporting_owner_cik": "0001563545",
      "reporting_owner_position": "EVP, CHIEF OPERATIONS OFFICER",
      "transaction_date": "2024-02-21",
      "transaction_shares": "52870",
      "transaction_price": "58.88",
      "transaction_type": "M",
      "shares_after_transaction": "296814"
    },
    {
      "id": 44014,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "SALEKI-GERHARDT AZITA",
      "reporting_owner_cik": "0001563545",
      "reporting_owner_position": "EVP, CHIEF OPERATIONS OFFICER",
      "transaction_date": "2024-02-21",
      "transaction_shares": "52870",
      "transaction_price": "58.88",
      "transaction_type": "M",
      "shares_after_transaction": "296814"
    },
    {
      "id": 63629,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "SALEKI-GERHARDT AZITA",
      "reporting_owner_cik": "0001563545",
      "reporting_owner_position": "EVP, CHIEF OPERATIONS OFFICER",
      "transaction_date": "2024-02-21",
      "transaction_shares": "52870",
      "transaction_price": "58.88",
      "transaction_type": "M",
      "shares_after_transaction": "296814"
    },
    {
      "id": 85537,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "SALEKI-GERHARDT AZITA",
      "reporting_owner_cik": "0001563545",
      "reporting_owner_position": "EVP, CHIEF OPERATIONS OFFICER",
      "transaction_date": "2024-02-21",
      "transaction_shares": "52870",
      "transaction_price": "58.88",
      "transaction_type": "M",
      "shares_after_transaction": "296814"
    },
    {
      "id": 4499,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Thakkar Roopal",
      "reporting_owner_cik": "0002004979",
      "reporting_owner_position": "SVP, CMO, GLOBAL THERAPEUTICS",
      "transaction_date": "2024-02-15",
      "transaction_shares": "8022",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "18399"
    },
    {
      "id": 4500,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Siatis Perry C",
      "reporting_owner_cik": "0001951400",
      "reporting_owner_position": "EVP, GC AND SECRETARY",
      "transaction_date": "2024-02-15",
      "transaction_shares": "8022",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "18399"
    },
    {
      "id": 4501,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "RICHMOND TIMOTHY J.",
      "reporting_owner_cik": "0001563523",
      "reporting_owner_position": "EVP, CHIEF HR OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "32097",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "45934"
    },
    {
      "id": 4502,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "GONZALEZ RICHARD A",
      "reporting_owner_cik": "0001239127",
      "reporting_owner_position": "CHAIRMAN OF THE BOARD AND CEO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "146335",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "669629"
    },
    {
      "id": 4503,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "SALEKI-GERHARDT AZITA",
      "reporting_owner_cik": "0001563545",
      "reporting_owner_position": "EVP, CHIEF OPERATIONS OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "32097",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "221946"
    },
    {
      "id": 4504,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Hudson Thomas J",
      "reporting_owner_cik": "0001781947",
      "reporting_owner_position": "SVP, CSO, GLOBAL RESEARCH",
      "transaction_date": "2024-02-15",
      "transaction_shares": "28322",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "109651"
    },
    {
      "id": 4506,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Donoghoe Nicholas",
      "reporting_owner_cik": "0001762951",
      "reporting_owner_position": "EVP, CHIEF BUS/STRAT OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "22657",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "78560"
    },
    {
      "id": 4507,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Buckbee Kevin K",
      "reporting_owner_cik": "0001968528",
      "reporting_owner_position": "SVP, CONTROLLER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "7080",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "14243"
    },
    {
      "id": 4508,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Reents Scott T",
      "reporting_owner_cik": "0001937048",
      "reporting_owner_position": "EVP, CHIEF FINANCIAL OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "11800",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12609"
    },
    {
      "id": 4509,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Michael Robert A.",
      "reporting_owner_cik": "0001699914",
      "reporting_owner_position": "PRES & CHIEF OPERATING OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "49565",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "148210"
    },
    {
      "id": 4510,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Stewart Jeffrey Ryan",
      "reporting_owner_cik": "0001761675",
      "reporting_owner_position": "EVP, CHIEF COMMERCIAL OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "33042",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "93983"
    },
    {
      "id": 14323,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Thakkar Roopal",
      "reporting_owner_cik": "0002004979",
      "reporting_owner_position": "SVP, CMO, GLOBAL THERAPEUTICS",
      "transaction_date": "2024-02-15",
      "transaction_shares": "8022",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "18399"
    },
    {
      "id": 14325,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Siatis Perry C",
      "reporting_owner_cik": "0001951400",
      "reporting_owner_position": "EVP, GC AND SECRETARY",
      "transaction_date": "2024-02-15",
      "transaction_shares": "8022",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "18399"
    },
    {
      "id": 14332,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "RICHMOND TIMOTHY J.",
      "reporting_owner_cik": "0001563523",
      "reporting_owner_position": "EVP, CHIEF HR OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "32097",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "45934"
    },
    {
      "id": 14334,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "GONZALEZ RICHARD A",
      "reporting_owner_cik": "0001239127",
      "reporting_owner_position": "CHAIRMAN OF THE BOARD AND CEO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "146335",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "669629"
    },
    {
      "id": 14335,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "SALEKI-GERHARDT AZITA",
      "reporting_owner_cik": "0001563545",
      "reporting_owner_position": "EVP, CHIEF OPERATIONS OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "32097",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "221946"
    },
    {
      "id": 14336,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Hudson Thomas J",
      "reporting_owner_cik": "0001781947",
      "reporting_owner_position": "SVP, CSO, GLOBAL RESEARCH",
      "transaction_date": "2024-02-15",
      "transaction_shares": "28322",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "109651"
    },
    {
      "id": 14340,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Donoghoe Nicholas",
      "reporting_owner_cik": "0001762951",
      "reporting_owner_position": "EVP, CHIEF BUS/STRAT OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "22657",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "78560"
    },
    {
      "id": 14341,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Buckbee Kevin K",
      "reporting_owner_cik": "0001968528",
      "reporting_owner_position": "SVP, CONTROLLER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "7080",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "14243"
    },
    {
      "id": 14343,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Reents Scott T",
      "reporting_owner_cik": "0001937048",
      "reporting_owner_position": "EVP, CHIEF FINANCIAL OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "11800",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12609"
    },
    {
      "id": 14344,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Michael Robert A.",
      "reporting_owner_cik": "0001699914",
      "reporting_owner_position": "PRES & CHIEF OPERATING OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "49565",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "148210"
    },
    {
      "id": 14350,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Stewart Jeffrey Ryan",
      "reporting_owner_cik": "0001761675",
      "reporting_owner_position": "EVP, CHIEF COMMERCIAL OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "33042",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "93983"
    },
    {
      "id": 27181,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Thakkar Roopal",
      "reporting_owner_cik": "0002004979",
      "reporting_owner_position": "SVP, CMO, GLOBAL THERAPEUTICS",
      "transaction_date": "2024-02-15",
      "transaction_shares": "8022",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "18399"
    },
    {
      "id": 27183,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Siatis Perry C",
      "reporting_owner_cik": "0001951400",
      "reporting_owner_position": "EVP, GC AND SECRETARY",
      "transaction_date": "2024-02-15",
      "transaction_shares": "8022",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "18399"
    },
    {
      "id": 27193,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "RICHMOND TIMOTHY J.",
      "reporting_owner_cik": "0001563523",
      "reporting_owner_position": "EVP, CHIEF HR OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "32097",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "45934"
    },
    {
      "id": 27195,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "GONZALEZ RICHARD A",
      "reporting_owner_cik": "0001239127",
      "reporting_owner_position": "CHAIRMAN OF THE BOARD AND CEO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "146335",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "669629"
    },
    {
      "id": 27196,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "SALEKI-GERHARDT AZITA",
      "reporting_owner_cik": "0001563545",
      "reporting_owner_position": "EVP, CHIEF OPERATIONS OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "32097",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "221946"
    },
    {
      "id": 27197,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Hudson Thomas J",
      "reporting_owner_cik": "0001781947",
      "reporting_owner_position": "SVP, CSO, GLOBAL RESEARCH",
      "transaction_date": "2024-02-15",
      "transaction_shares": "28322",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "109651"
    },
    {
      "id": 27201,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Donoghoe Nicholas",
      "reporting_owner_cik": "0001762951",
      "reporting_owner_position": "EVP, CHIEF BUS/STRAT OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "22657",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "78560"
    },
    {
      "id": 27202,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Buckbee Kevin K",
      "reporting_owner_cik": "0001968528",
      "reporting_owner_position": "SVP, CONTROLLER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "7080",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "14243"
    },
    {
      "id": 27204,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Reents Scott T",
      "reporting_owner_cik": "0001937048",
      "reporting_owner_position": "EVP, CHIEF FINANCIAL OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "11800",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12609"
    },
    {
      "id": 27205,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Michael Robert A.",
      "reporting_owner_cik": "0001699914",
      "reporting_owner_position": "PRES & CHIEF OPERATING OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "49565",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "148210"
    },
    {
      "id": 27211,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Stewart Jeffrey Ryan",
      "reporting_owner_cik": "0001761675",
      "reporting_owner_position": "EVP, CHIEF COMMERCIAL OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "33042",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "93983"
    },
    {
      "id": 44008,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Thakkar Roopal",
      "reporting_owner_cik": "0002004979",
      "reporting_owner_position": "SVP, CMO, GLOBAL THERAPEUTICS",
      "transaction_date": "2024-02-15",
      "transaction_shares": "8022",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "18399"
    },
    {
      "id": 44012,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Siatis Perry C",
      "reporting_owner_cik": "0001951400",
      "reporting_owner_position": "EVP, GC AND SECRETARY",
      "transaction_date": "2024-02-15",
      "transaction_shares": "8022",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "18399"
    },
    {
      "id": 44026,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "RICHMOND TIMOTHY J.",
      "reporting_owner_cik": "0001563523",
      "reporting_owner_position": "EVP, CHIEF HR OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "32097",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "45934"
    },
    {
      "id": 44028,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "GONZALEZ RICHARD A",
      "reporting_owner_cik": "0001239127",
      "reporting_owner_position": "CHAIRMAN OF THE BOARD AND CEO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "146335",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "669629"
    },
    {
      "id": 44029,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "SALEKI-GERHARDT AZITA",
      "reporting_owner_cik": "0001563545",
      "reporting_owner_position": "EVP, CHIEF OPERATIONS OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "32097",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "221946"
    },
    {
      "id": 44031,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Hudson Thomas J",
      "reporting_owner_cik": "0001781947",
      "reporting_owner_position": "SVP, CSO, GLOBAL RESEARCH",
      "transaction_date": "2024-02-15",
      "transaction_shares": "28322",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "109651"
    },
    {
      "id": 44036,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Donoghoe Nicholas",
      "reporting_owner_cik": "0001762951",
      "reporting_owner_position": "EVP, CHIEF BUS/STRAT OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "22657",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "78560"
    },
    {
      "id": 44037,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Buckbee Kevin K",
      "reporting_owner_cik": "0001968528",
      "reporting_owner_position": "SVP, CONTROLLER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "7080",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "14243"
    },
    {
      "id": 44039,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Reents Scott T",
      "reporting_owner_cik": "0001937048",
      "reporting_owner_position": "EVP, CHIEF FINANCIAL OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "11800",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12609"
    },
    {
      "id": 44040,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Michael Robert A.",
      "reporting_owner_cik": "0001699914",
      "reporting_owner_position": "PRES & CHIEF OPERATING OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "49565",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "148210"
    },
    {
      "id": 44049,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Stewart Jeffrey Ryan",
      "reporting_owner_cik": "0001761675",
      "reporting_owner_position": "EVP, CHIEF COMMERCIAL OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "33042",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "93983"
    },
    {
      "id": 63623,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Thakkar Roopal",
      "reporting_owner_cik": "0002004979",
      "reporting_owner_position": "SVP, CMO, GLOBAL THERAPEUTICS",
      "transaction_date": "2024-02-15",
      "transaction_shares": "8022",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "18399"
    },
    {
      "id": 63627,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Siatis Perry C",
      "reporting_owner_cik": "0001951400",
      "reporting_owner_position": "EVP, GC AND SECRETARY",
      "transaction_date": "2024-02-15",
      "transaction_shares": "8022",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "18399"
    },
    {
      "id": 63641,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "RICHMOND TIMOTHY J.",
      "reporting_owner_cik": "0001563523",
      "reporting_owner_position": "EVP, CHIEF HR OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "32097",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "45934"
    },
    {
      "id": 63643,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "GONZALEZ RICHARD A",
      "reporting_owner_cik": "0001239127",
      "reporting_owner_position": "CHAIRMAN OF THE BOARD AND CEO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "146335",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "669629"
    },
    {
      "id": 63644,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "SALEKI-GERHARDT AZITA",
      "reporting_owner_cik": "0001563545",
      "reporting_owner_position": "EVP, CHIEF OPERATIONS OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "32097",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "221946"
    },
    {
      "id": 63646,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Hudson Thomas J",
      "reporting_owner_cik": "0001781947",
      "reporting_owner_position": "SVP, CSO, GLOBAL RESEARCH",
      "transaction_date": "2024-02-15",
      "transaction_shares": "28322",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "109651"
    },
    {
      "id": 63651,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Donoghoe Nicholas",
      "reporting_owner_cik": "0001762951",
      "reporting_owner_position": "EVP, CHIEF BUS/STRAT OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "22657",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "78560"
    },
    {
      "id": 63652,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Buckbee Kevin K",
      "reporting_owner_cik": "0001968528",
      "reporting_owner_position": "SVP, CONTROLLER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "7080",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "14243"
    },
    {
      "id": 63654,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Reents Scott T",
      "reporting_owner_cik": "0001937048",
      "reporting_owner_position": "EVP, CHIEF FINANCIAL OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "11800",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12609"
    },
    {
      "id": 63655,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Michael Robert A.",
      "reporting_owner_cik": "0001699914",
      "reporting_owner_position": "PRES & CHIEF OPERATING OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "49565",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "148210"
    },
    {
      "id": 63664,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Stewart Jeffrey Ryan",
      "reporting_owner_cik": "0001761675",
      "reporting_owner_position": "EVP, CHIEF COMMERCIAL OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "33042",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "93983"
    },
    {
      "id": 85529,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Thakkar Roopal",
      "reporting_owner_cik": "0002004979",
      "reporting_owner_position": "SVP, CMO, GLOBAL THERAPEUTICS",
      "transaction_date": "2024-02-15",
      "transaction_shares": "8022",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "18399"
    },
    {
      "id": 85535,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Siatis Perry C",
      "reporting_owner_cik": "0001951400",
      "reporting_owner_position": "EVP, GC AND SECRETARY",
      "transaction_date": "2024-02-15",
      "transaction_shares": "8022",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "18399"
    },
    {
      "id": 85549,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "RICHMOND TIMOTHY J.",
      "reporting_owner_cik": "0001563523",
      "reporting_owner_position": "EVP, CHIEF HR OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "32097",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "45934"
    },
    {
      "id": 85551,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "GONZALEZ RICHARD A",
      "reporting_owner_cik": "0001239127",
      "reporting_owner_position": "CHAIRMAN OF THE BOARD AND CEO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "146335",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "669629"
    },
    {
      "id": 85552,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "SALEKI-GERHARDT AZITA",
      "reporting_owner_cik": "0001563545",
      "reporting_owner_position": "EVP, CHIEF OPERATIONS OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "32097",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "221946"
    },
    {
      "id": 85555,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Hudson Thomas J",
      "reporting_owner_cik": "0001781947",
      "reporting_owner_position": "SVP, CSO, GLOBAL RESEARCH",
      "transaction_date": "2024-02-15",
      "transaction_shares": "28322",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "109651"
    },
    {
      "id": 85560,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Donoghoe Nicholas",
      "reporting_owner_cik": "0001762951",
      "reporting_owner_position": "EVP, CHIEF BUS/STRAT OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "22657",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "78560"
    },
    {
      "id": 85561,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Buckbee Kevin K",
      "reporting_owner_cik": "0001968528",
      "reporting_owner_position": "SVP, CONTROLLER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "7080",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "14243"
    },
    {
      "id": 85563,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Reents Scott T",
      "reporting_owner_cik": "0001937048",
      "reporting_owner_position": "EVP, CHIEF FINANCIAL OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "11800",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12609"
    },
    {
      "id": 85564,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Michael Robert A.",
      "reporting_owner_cik": "0001699914",
      "reporting_owner_position": "PRES & CHIEF OPERATING OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "49565",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "148210"
    },
    {
      "id": 85574,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Stewart Jeffrey Ryan",
      "reporting_owner_cik": "0001761675",
      "reporting_owner_position": "EVP, CHIEF COMMERCIAL OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "33042",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "93983"
    },
    {
      "id": 4505,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Siatis Perry C",
      "reporting_owner_cik": "0001951400",
      "reporting_owner_position": "EVP, GC AND SECRETARY",
      "transaction_date": "2024-02-02",
      "transaction_shares": "2919",
      "transaction_price": "144.54",
      "transaction_type": "A",
      "shares_after_transaction": "13296"
    },
    {
      "id": 14338,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Siatis Perry C",
      "reporting_owner_cik": "0001951400",
      "reporting_owner_position": "EVP, GC AND SECRETARY",
      "transaction_date": "2024-02-02",
      "transaction_shares": "2919",
      "transaction_price": "144.54",
      "transaction_type": "A",
      "shares_after_transaction": "13296"
    },
    {
      "id": 27199,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Siatis Perry C",
      "reporting_owner_cik": "0001951400",
      "reporting_owner_position": "EVP, GC AND SECRETARY",
      "transaction_date": "2024-02-02",
      "transaction_shares": "2919",
      "transaction_price": "144.54",
      "transaction_type": "A",
      "shares_after_transaction": "13296"
    },
    {
      "id": 44033,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Siatis Perry C",
      "reporting_owner_cik": "0001951400",
      "reporting_owner_position": "EVP, GC AND SECRETARY",
      "transaction_date": "2024-02-02",
      "transaction_shares": "2919",
      "transaction_price": "144.54",
      "transaction_type": "A",
      "shares_after_transaction": "13296"
    },
    {
      "id": 63648,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Siatis Perry C",
      "reporting_owner_cik": "0001951400",
      "reporting_owner_position": "EVP, GC AND SECRETARY",
      "transaction_date": "2024-02-02",
      "transaction_shares": "2919",
      "transaction_price": "144.54",
      "transaction_type": "A",
      "shares_after_transaction": "13296"
    },
    {
      "id": 85557,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Siatis Perry C",
      "reporting_owner_cik": "0001951400",
      "reporting_owner_position": "EVP, GC AND SECRETARY",
      "transaction_date": "2024-02-02",
      "transaction_shares": "2919",
      "transaction_price": "144.54",
      "transaction_type": "A",
      "shares_after_transaction": "13296"
    }
  ]
}